1 / 5

Plasma Fractionation Market Global Opportunities, Industry Analysis, Size, Share, Demand, Growth, and Forecast 2026

The increasing prevalence of respiratory diseases and alpha-1 antitrypsin deficiency among people worldwide is boosting the global plasma fractionation market, says Fortune Business Insights in a new study. The report, titled u201cPlasma Fractionation: Global Market Analysis, Insights, and Forecasts 2018 to 2026,u201d offers insights into growth drivers and restraints impacting the plasma fractionation market.<br><br>Browse Complete Report:<br>https://www.fortunebusinessinsights.com/industry-reports/plasma-fractionation-market-101614<br>

NitaSonwane
Download Presentation

Plasma Fractionation Market Global Opportunities, Industry Analysis, Size, Share, Demand, Growth, and Forecast 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Plasma Fractionation Market Size, Share & Industry Analysis, By Product Type (Albumin, Immunoglobulin (Intravenous Immunoglobulin and Subcutaneous Immunoglobulin), Coagulation Factors, Protease Inhibitors and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology and Others), By End User (Hospitals & Clinics,), and Geography Forecast 2019-2026 Buy Now Sample PDF Get Discount Published Date: April 2019 Region: Global Report Format: PDF Base Year: 2018 Fortune Business Insights Pvt Ltd.

  2. Plasma Fractionation Market Size, Share & Industry Analysis, By Product Type (Albumin, Immunoglobulin (Intravenous Immunoglobulin and Subcutaneous Immunoglobulin), Coagulation Factors, Protease Inhibitors and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology and Others), By End User (Hospitals & Clinics,), and Geography Forecast 2019-2026 Report Highlights: The increasing prevalence of respiratory diseases and alpha-1 antitrypsin deficiency among people worldwide is boosting the global plasma fractionation market, says Fortune Business Insights in a new study. The report, titled “Plasma Fractionation: Global Market Analysis, Insights, and Forecasts 2018 to 2026,” offers insights into growth drivers and restraints impacting the plasma fractionation market. According to the report, the global market for plasma fractionation is estimated to rise at a CAGR of 6.2% and reach a value of US$ 38,652.1 Mn by 2026 from US$ 24,078.5 Mn in 2018. In terms of product, the market is anticipated to be dominated by the immunoglobulin segment as they play a major role in detecting and destroying the bacteria present in the body. In the year 2018, immunoglobulin segment accounted for about 47.7% share in the global market. On the other side, the protease inhibitors segment is anticipated to exhibit the growth at the fastest rate. This is attributable to the fact that protease inhibitors are used as antiviral agents and help to prevent infection. In addition to that, the use of these inhibitors for HIV is anticipated to drive the over the forecast period. Fortune Business Insights Pvt Ltd.

  3. Plasma Fractionation Market Size, Share & Industry Analysis, By Product Type (Albumin, Immunoglobulin (Intravenous Immunoglobulin and Subcutaneous Immunoglobulin), Coagulation Factors, Protease Inhibitors and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology and Others), By End User (Hospitals & Clinics,), and Geography Forecast 2019-2026 Rise in Number of Diagnostic Centers for using Plasma Proteins as Therapeutics to Bode Well for Market The rising awareness about diseases because of the expansion of media and increasing number of diagnostic centers have increased the value of plasma fractionation. This is a major factor boosting the overall market. In addition to that, increasing investments made in designing of therapeutics for chronic diseases is also anticipated to drive the global market. Besides this, the increasing popularity and usage of proteins derived from plasma for various treatments is presumed to bode well for the global market. North America Emerges Dominant on Account of Better Healthcare Infrastructures Geographically, the global market for plasma fractionation is dominated by North America at present. Factors promoting growth in this region are better healthcare infrastructures, government supported reimbursement policies, and presence of large company in developed nations of the region namely Canada and the U.S. Moreover, recent approvals from the Food and Drug (FDA) favor the growth of new plasma fractionation facilities are thus creating lucrative growth opportunities for the market in North America. Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/plasma-fractionation-market-101614 Fortune Business Insights Pvt Ltd.

  4. Plasma Fractionation Market Size, Share & Industry Analysis, By Product Type (Albumin, Immunoglobulin (Intravenous Immunoglobulin and Subcutaneous Immunoglobulin), Coagulation Factors, Protease Inhibitors and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology and Others), By End User (Hospitals & Clinics,), and Geography Forecast 2019-2026 List of the companies functioning in the global market are: • LFB • Shire • Japan Blood Products Organization • Biotest AG • Grifols, S.A. • G.C. Pharma (Green Cross Corporation) • Octapharma • Sanquin • Kedrion S.p.A. • Baxter • China Biologic Products • CSL • Shanghai RAAS Blood Products Get Customization: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/plasma-fractionation-market- 101614 Fortune Business Insights Pvt Ltd.

  5. Plasma Fractionation Market Size, Share & Industry Analysis, By Product Type (Albumin, Immunoglobulin (Intravenous Immunoglobulin and Subcutaneous Immunoglobulin), Coagulation Factors, Protease Inhibitors and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology and Others), By End User (Hospitals & Clinics,), and Geography Forecast 2019-2026 About Us: Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. Phone: US: +1 424 253 0390 UK: +44 2071 939123 APAC: +91 744 740 1245 Email: sales@fortunebusinessinsights.com Fortune Business Insights Pvt Ltd.

More Related